Huarun Shuanghe Limin Pharmaceutical (Ji'nan) Co., Ltd.
-
Founded in:
2001-06-28 -
Country:
China -
Address:
No. 1, Limin Road, Mingshui Street, Zhangqiu District, Jinan City, Shandong Province -
Tax NO.:
91370181163446867C -
Registered Funds:
23.85 million yuan -
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Cytidine 5'-triphosphate disodium salt |
Coenzyme drugs are nucleotide derivatives that participate in the synthesis and metabolism of phospholipids and nucleic acids in the body. They are intermediate products and energy sources for brain phospholipid synthesis and nucleic acid metabolism.
More
Coenzyme drugs are nucleotide derivatives that participate in the synthesis and metabolism of phospholipids and nucleic acids in the body. They are intermediate products and energy sources for brain phospholipid synthesis and nucleic acid metabolism. |
36051-68-0 | 10 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Granisetron Hydrochloride |
This product is a highly selective 5-HT3 receptor antagonist, which inhibits the occurrence of nausea and vomiting by antagonizing the 5-HT3 receptors in the central chemoreceptor area and peripheral vagus nerve endings. It has high selectivity and no adverse reactions such as extrapyramidal reactions and excessive sedation.
More
This product is a highly selective 5-HT3 receptor antagonist, which inhibits the occurrence of nausea and vomiting by antagonizing the 5-HT3 receptors in the central chemoreceptor area and peripheral vagus nerve endings. It has high selectivity and no adverse reactions such as extrapyramidal reactions and excessive sedation. |
107007-99-8 | 35 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Propyl gallate |
It has the effect of inhibiting platelet aggregation caused by (TXA2); it can reduce whole blood viscosity and plasma specific viscosity, accelerate the electrophoresis of red blood cells, relax vascular smooth muscle, and increase coronary blood flow; it has a significant protective effect on myocardial ischemia.
More
It has the effect of inhibiting platelet aggregation caused by (TXA2); it can reduce whole blood viscosity and plasma specific viscosity, accelerate the electrophoresis of red blood cells, relax vascular smooth muscle, and increase coronary blood flow; it has a significant protective effect on myocardial ischemia. |
121-79-9 | 10 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Propyl gallate |
It has the effect of inhibiting platelet aggregation caused by (TXA2); it can reduce whole blood viscosity and plasma specific viscosity, accelerate the electrophoresis of red blood cells, relax vascular smooth muscle, and increase coronary blood flow; it has a significant protective effect on myocardial ischemia.
More
It has the effect of inhibiting platelet aggregation caused by (TXA2); it can reduce whole blood viscosity and plasma specific viscosity, accelerate the electrophoresis of red blood cells, relax vascular smooth muscle, and increase coronary blood flow; it has a significant protective effect on myocardial ischemia. |
121-79-9 | 10 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Simvastatin |
This product is a methylhydroxyglutaryl coenzyme A (HMG-COA) reductase inhibitor, which inhibits the synthesis of endogenous cholesterol and is a blood lipid regulator. Literature data show that it can reduce the cholesterol (TC) content in the serum, liver, and aorta of hyperlipidemia rabbits, and reduce the levels of very low density lipoprotein cholesterol (VLDL-C) and low density lipoprotein cholesterol (LDL-C).
More
This product is a methylhydroxyglutaryl coenzyme A (HMG-COA) reductase inhibitor, which inhibits the synthesis of endogenous cholesterol and is a blood lipid regulator. Literature data show that it can reduce the cholesterol (TC) content in the serum, liver, and aorta of hyperlipidemia rabbits, and reduce the levels of very low density lipoprotein cholesterol (VLDL-C) and low density lipoprotein cholesterol (LDL-C). |
79902-63-9 | 63 |